nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—UGT2B7—Epirubicin—pancreatic cancer	0.0563	0.0772	CbGbCtD
Lovastatin—UGT1A1—Erlotinib—pancreatic cancer	0.0524	0.0718	CbGbCtD
Lovastatin—UGT1A1—Irinotecan—pancreatic cancer	0.0473	0.0649	CbGbCtD
Lovastatin—ABCC2—Tamoxifen—pancreatic cancer	0.0375	0.0514	CbGbCtD
Lovastatin—SLCO1B1—Irinotecan—pancreatic cancer	0.0328	0.0449	CbGbCtD
Lovastatin—ABCC2—Irinotecan—pancreatic cancer	0.0288	0.0395	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.025	0.0343	CbGbCtD
Lovastatin—CYP3A7—Tamoxifen—pancreatic cancer	0.025	0.0343	CbGbCtD
Lovastatin—ABCC2—Docetaxel—pancreatic cancer	0.0211	0.0289	CbGbCtD
Lovastatin—ABCC2—Sunitinib—pancreatic cancer	0.021	0.0288	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0192	0.0264	CbGbCtD
Lovastatin—CYP3A7—Irinotecan—pancreatic cancer	0.0192	0.0264	CbGbCtD
Lovastatin—CYP3A5—Tamoxifen—pancreatic cancer	0.0188	0.0257	CbGbCtD
Lovastatin—CYP2C8—Tamoxifen—pancreatic cancer	0.0181	0.0248	CbGbCtD
Lovastatin—CYP3A5—Erlotinib—pancreatic cancer	0.016	0.0219	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—pancreatic cancer	0.0157	0.0216	CbGbCtD
Lovastatin—CYP2C8—Erlotinib—pancreatic cancer	0.0154	0.021	CbGbCtD
Lovastatin—CYP2C19—Tamoxifen—pancreatic cancer	0.0151	0.0208	CbGbCtD
Lovastatin—CYP3A5—Irinotecan—pancreatic cancer	0.0144	0.0198	CbGbCtD
Lovastatin—CYP3A7—Docetaxel—pancreatic cancer	0.0141	0.0193	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0141	0.0193	CbGbCtD
Lovastatin—CYP3A7—Sunitinib—pancreatic cancer	0.014	0.0192	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.014	0.0192	CbGbCtD
Lovastatin—CYP2C8—Fluorouracil—pancreatic cancer	0.0133	0.0182	CbGbCtD
Lovastatin—CYP2C9—Tamoxifen—pancreatic cancer	0.0126	0.0173	CbGbCtD
Lovastatin—ABCB1—Tamoxifen—pancreatic cancer	0.0122	0.0168	CbGbCtD
Lovastatin—CYP2D6—Tamoxifen—pancreatic cancer	0.0115	0.0158	CbGbCtD
Lovastatin—CYP3A5—Docetaxel—pancreatic cancer	0.0106	0.0145	CbGbCtD
Lovastatin—ABCB1—Gemcitabine—pancreatic cancer	0.0105	0.0144	CbGbCtD
Lovastatin—CYP3A5—Sunitinib—pancreatic cancer	0.0105	0.0144	CbGbCtD
Lovastatin—ABCB1—Erlotinib—pancreatic cancer	0.0104	0.0142	CbGbCtD
Lovastatin—CYP2D6—Erlotinib—pancreatic cancer	0.00979	0.0134	CbGbCtD
Lovastatin—ABCB1—Irinotecan—pancreatic cancer	0.00938	0.0129	CbGbCtD
Lovastatin—CYP2C9—Fluorouracil—pancreatic cancer	0.00928	0.0127	CbGbCtD
Lovastatin—ABCC2—bile duct—pancreatic cancer	0.00779	0.178	CbGeAlD
Lovastatin—CYP3A4—Tamoxifen—pancreatic cancer	0.00732	0.01	CbGbCtD
Lovastatin—ABCB1—Docetaxel—pancreatic cancer	0.00688	0.00943	CbGbCtD
Lovastatin—ABCB1—Sunitinib—pancreatic cancer	0.00685	0.00939	CbGbCtD
Lovastatin—CYP3A4—Erlotinib—pancreatic cancer	0.00623	0.00854	CbGbCtD
Lovastatin—ABCC2—bile—pancreatic cancer	0.00599	0.137	CbGeAlD
Lovastatin—CYP3A4—Irinotecan—pancreatic cancer	0.00562	0.00771	CbGbCtD
Lovastatin—ABCB1—Doxorubicin—pancreatic cancer	0.00513	0.00703	CbGbCtD
Lovastatin—CYP2D6—Doxorubicin—pancreatic cancer	0.00483	0.00662	CbGbCtD
Lovastatin—CYP3A4—Docetaxel—pancreatic cancer	0.00412	0.00565	CbGbCtD
Lovastatin—CYP3A4—Sunitinib—pancreatic cancer	0.0041	0.00562	CbGbCtD
Lovastatin—PON3—islet of Langerhans—pancreatic cancer	0.00408	0.0934	CbGeAlD
Lovastatin—CYP3A4—Doxorubicin—pancreatic cancer	0.00307	0.00421	CbGbCtD
Lovastatin—PON3—pancreas—pancreatic cancer	0.00287	0.0657	CbGeAlD
Lovastatin—ITGAL—digestive system—pancreatic cancer	0.0025	0.0572	CbGeAlD
Lovastatin—HDAC2—Topotecan—Irinotecan—pancreatic cancer	0.00233	0.598	CbGdCrCtD
Lovastatin—HMGCR—gall bladder—pancreatic cancer	0.00229	0.0524	CbGeAlD
Lovastatin—UGT1A3—digestive system—pancreatic cancer	0.00212	0.0486	CbGeAlD
Lovastatin—HDAC2—islet of Langerhans—pancreatic cancer	0.00166	0.0381	CbGeAlD
Lovastatin—HDAC2—Gefitinib—Erlotinib—pancreatic cancer	0.00157	0.403	CbGdCrCtD
Lovastatin—HMGCR—islet of Langerhans—pancreatic cancer	0.0015	0.0344	CbGeAlD
Lovastatin—UGT2B7—digestive system—pancreatic cancer	0.00122	0.0279	CbGeAlD
Lovastatin—HDAC2—pancreas—pancreatic cancer	0.00117	0.0268	CbGeAlD
Lovastatin—HMGCR—pancreas—pancreatic cancer	0.00105	0.0242	CbGeAlD
Lovastatin—UGT1A1—digestive system—pancreatic cancer	0.00104	0.0238	CbGeAlD
Lovastatin—HDAC2—digestive system—pancreatic cancer	0.000998	0.0229	CbGeAlD
Lovastatin—HMGCR—digestive system—pancreatic cancer	0.000901	0.0206	CbGeAlD
Lovastatin—SLCO1B1—digestive system—pancreatic cancer	0.000863	0.0198	CbGeAlD
Lovastatin—CYP3A5—islet of Langerhans—pancreatic cancer	0.000738	0.0169	CbGeAlD
Lovastatin—SLCO1A2—digestive system—pancreatic cancer	0.000702	0.0161	CbGeAlD
Lovastatin—ABCC2—digestive system—pancreatic cancer	0.000654	0.015	CbGeAlD
Lovastatin—CYP2C19—digestive system—pancreatic cancer	0.000562	0.0129	CbGeAlD
Lovastatin—CYP3A5—pancreas—pancreatic cancer	0.000518	0.0119	CbGeAlD
Lovastatin—CYP3A5—digestive system—pancreatic cancer	0.000443	0.0101	CbGeAlD
Lovastatin—CYP2C9—digestive system—pancreatic cancer	0.000436	0.00998	CbGeAlD
Lovastatin—ABCB1—islet of Langerhans—pancreatic cancer	0.000392	0.00898	CbGeAlD
Lovastatin—CYP3A4—digestive system—pancreatic cancer	0.000332	0.00761	CbGeAlD
Lovastatin—CYP2D6—digestive system—pancreatic cancer	0.000327	0.00749	CbGeAlD
Lovastatin—ABCB1—pancreas—pancreatic cancer	0.000275	0.00631	CbGeAlD
Lovastatin—ABCB1—digestive system—pancreatic cancer	0.000235	0.00539	CbGeAlD
Lovastatin—Confusional state—Fluorouracil—pancreatic cancer	0.000229	0.00169	CcSEcCtD
Lovastatin—Abdominal pain—Sunitinib—pancreatic cancer	0.000227	0.00167	CcSEcCtD
Lovastatin—Body temperature increased—Sunitinib—pancreatic cancer	0.000227	0.00167	CcSEcCtD
Lovastatin—Diarrhoea—Erlotinib—pancreatic cancer	0.000227	0.00167	CcSEcCtD
Lovastatin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000227	0.00167	CcSEcCtD
Lovastatin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000226	0.00166	CcSEcCtD
Lovastatin—Anorexia—Irinotecan—pancreatic cancer	0.000226	0.00166	CcSEcCtD
Lovastatin—Infection—Fluorouracil—pancreatic cancer	0.000226	0.00166	CcSEcCtD
Lovastatin—Pain in extremity—Epirubicin—pancreatic cancer	0.000225	0.00166	CcSEcCtD
Lovastatin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000222	0.00164	CcSEcCtD
Lovastatin—Dizziness—Tamoxifen—pancreatic cancer	0.000222	0.00164	CcSEcCtD
Lovastatin—Anorexia—Gemcitabine—pancreatic cancer	0.00022	0.00162	CcSEcCtD
Lovastatin—Dizziness—Erlotinib—pancreatic cancer	0.00022	0.00162	CcSEcCtD
Lovastatin—Erythema multiforme—Docetaxel—pancreatic cancer	0.000218	0.00161	CcSEcCtD
Lovastatin—Anorexia—Fluorouracil—pancreatic cancer	0.000216	0.00159	CcSEcCtD
Lovastatin—Purpura—Doxorubicin—pancreatic cancer	0.000216	0.00159	CcSEcCtD
Lovastatin—Insomnia—Irinotecan—pancreatic cancer	0.000214	0.00158	CcSEcCtD
Lovastatin—Flushing—Docetaxel—pancreatic cancer	0.000214	0.00158	CcSEcCtD
Lovastatin—Vomiting—Tamoxifen—pancreatic cancer	0.000214	0.00157	CcSEcCtD
Lovastatin—Paraesthesia—Irinotecan—pancreatic cancer	0.000213	0.00157	CcSEcCtD
Lovastatin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000212	0.00156	CcSEcCtD
Lovastatin—Rash—Tamoxifen—pancreatic cancer	0.000212	0.00156	CcSEcCtD
Lovastatin—Dermatitis—Tamoxifen—pancreatic cancer	0.000212	0.00156	CcSEcCtD
Lovastatin—Vomiting—Erlotinib—pancreatic cancer	0.000211	0.00156	CcSEcCtD
Lovastatin—Dyspnoea—Irinotecan—pancreatic cancer	0.000211	0.00156	CcSEcCtD
Lovastatin—Headache—Tamoxifen—pancreatic cancer	0.00021	0.00155	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00021	0.00155	CcSEcCtD
Lovastatin—Rash—Erlotinib—pancreatic cancer	0.00021	0.00154	CcSEcCtD
Lovastatin—Dermatitis—Erlotinib—pancreatic cancer	0.000209	0.00154	CcSEcCtD
Lovastatin—Insomnia—Gemcitabine—pancreatic cancer	0.000209	0.00154	CcSEcCtD
Lovastatin—Dyspepsia—Irinotecan—pancreatic cancer	0.000209	0.00154	CcSEcCtD
Lovastatin—Headache—Erlotinib—pancreatic cancer	0.000208	0.00153	CcSEcCtD
Lovastatin—Pain in extremity—Doxorubicin—pancreatic cancer	0.000208	0.00153	CcSEcCtD
Lovastatin—Paraesthesia—Gemcitabine—pancreatic cancer	0.000207	0.00153	CcSEcCtD
Lovastatin—Chills—Docetaxel—pancreatic cancer	0.000207	0.00152	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000207	0.00152	CcSEcCtD
Lovastatin—Asthenia—Sunitinib—pancreatic cancer	0.000206	0.00152	CcSEcCtD
Lovastatin—Decreased appetite—Irinotecan—pancreatic cancer	0.000206	0.00152	CcSEcCtD
Lovastatin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000206	0.00152	CcSEcCtD
Lovastatin—Insomnia—Fluorouracil—pancreatic cancer	0.000205	0.00151	CcSEcCtD
Lovastatin—Fatigue—Irinotecan—pancreatic cancer	0.000204	0.0015	CcSEcCtD
Lovastatin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000204	0.0015	CcSEcCtD
Lovastatin—Alopecia—Docetaxel—pancreatic cancer	0.000204	0.0015	CcSEcCtD
Lovastatin—Pruritus—Sunitinib—pancreatic cancer	0.000204	0.0015	CcSEcCtD
Lovastatin—Pain—Irinotecan—pancreatic cancer	0.000203	0.00149	CcSEcCtD
Lovastatin—Constipation—Irinotecan—pancreatic cancer	0.000203	0.00149	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000202	0.00149	CcSEcCtD
Lovastatin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000202	0.00149	CcSEcCtD
Lovastatin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000201	0.00148	CcSEcCtD
Lovastatin—Dyspepsia—Fluorouracil—pancreatic cancer	0.0002	0.00147	CcSEcCtD
Lovastatin—Nausea—Tamoxifen—pancreatic cancer	0.0002	0.00147	CcSEcCtD
Lovastatin—Fatigue—Gemcitabine—pancreatic cancer	0.000199	0.00147	CcSEcCtD
Lovastatin—Constipation—Gemcitabine—pancreatic cancer	0.000197	0.00145	CcSEcCtD
Lovastatin—Pain—Gemcitabine—pancreatic cancer	0.000197	0.00145	CcSEcCtD
Lovastatin—Nausea—Erlotinib—pancreatic cancer	0.000197	0.00145	CcSEcCtD
Lovastatin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000197	0.00145	CcSEcCtD
Lovastatin—Diarrhoea—Sunitinib—pancreatic cancer	0.000197	0.00145	CcSEcCtD
Lovastatin—Dysgeusia—Docetaxel—pancreatic cancer	0.000197	0.00145	CcSEcCtD
Lovastatin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000195	0.00144	CcSEcCtD
Lovastatin—Influenza—Epirubicin—pancreatic cancer	0.000194	0.00143	CcSEcCtD
Lovastatin—Back pain—Docetaxel—pancreatic cancer	0.000194	0.00143	CcSEcCtD
Lovastatin—Pain—Fluorouracil—pancreatic cancer	0.000194	0.00143	CcSEcCtD
Lovastatin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000194	0.00143	CcSEcCtD
Lovastatin—Muscle spasms—Docetaxel—pancreatic cancer	0.000193	0.00142	CcSEcCtD
Lovastatin—Eosinophilia—Epirubicin—pancreatic cancer	0.000192	0.00142	CcSEcCtD
Lovastatin—Pancreatitis—Epirubicin—pancreatic cancer	0.000191	0.0014	CcSEcCtD
Lovastatin—Dizziness—Sunitinib—pancreatic cancer	0.00019	0.0014	CcSEcCtD
Lovastatin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00019	0.0014	CcSEcCtD
Lovastatin—Abdominal pain—Irinotecan—pancreatic cancer	0.000187	0.00138	CcSEcCtD
Lovastatin—Body temperature increased—Irinotecan—pancreatic cancer	0.000187	0.00138	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000187	0.00138	CcSEcCtD
Lovastatin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000187	0.00138	CcSEcCtD
Lovastatin—Vomiting—Sunitinib—pancreatic cancer	0.000183	0.00135	CcSEcCtD
Lovastatin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000183	0.00134	CcSEcCtD
Lovastatin—Rash—Sunitinib—pancreatic cancer	0.000181	0.00134	CcSEcCtD
Lovastatin—Dermatitis—Sunitinib—pancreatic cancer	0.000181	0.00133	CcSEcCtD
Lovastatin—Urticaria—Fluorouracil—pancreatic cancer	0.00018	0.00133	CcSEcCtD
Lovastatin—Headache—Sunitinib—pancreatic cancer	0.00018	0.00133	CcSEcCtD
Lovastatin—Influenza—Doxorubicin—pancreatic cancer	0.00018	0.00132	CcSEcCtD
Lovastatin—Leukopenia—Docetaxel—pancreatic cancer	0.00018	0.00132	CcSEcCtD
Lovastatin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000179	0.00132	CcSEcCtD
Lovastatin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000178	0.00131	CcSEcCtD
Lovastatin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000177	0.00131	CcSEcCtD
Lovastatin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000176	0.0013	CcSEcCtD
Lovastatin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000175	0.00129	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000172	0.00127	CcSEcCtD
Lovastatin—Arthralgia—Docetaxel—pancreatic cancer	0.000171	0.00126	CcSEcCtD
Lovastatin—Myalgia—Docetaxel—pancreatic cancer	0.000171	0.00126	CcSEcCtD
Lovastatin—Chest pain—Docetaxel—pancreatic cancer	0.000171	0.00126	CcSEcCtD
Lovastatin—Nausea—Sunitinib—pancreatic cancer	0.000171	0.00126	CcSEcCtD
Lovastatin—Asthenia—Irinotecan—pancreatic cancer	0.00017	0.00125	CcSEcCtD
Lovastatin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00017	0.00125	CcSEcCtD
Lovastatin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000168	0.00124	CcSEcCtD
Lovastatin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000167	0.00123	CcSEcCtD
Lovastatin—Dry mouth—Docetaxel—pancreatic cancer	0.000167	0.00123	CcSEcCtD
Lovastatin—Asthenia—Gemcitabine—pancreatic cancer	0.000166	0.00122	CcSEcCtD
Lovastatin—Confusional state—Docetaxel—pancreatic cancer	0.000165	0.00122	CcSEcCtD
Lovastatin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000164	0.00121	CcSEcCtD
Lovastatin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000164	0.00121	CcSEcCtD
Lovastatin—Pruritus—Gemcitabine—pancreatic cancer	0.000163	0.0012	CcSEcCtD
Lovastatin—Infection—Docetaxel—pancreatic cancer	0.000163	0.0012	CcSEcCtD
Lovastatin—Sinusitis—Epirubicin—pancreatic cancer	0.000163	0.0012	CcSEcCtD
Lovastatin—Diarrhoea—Irinotecan—pancreatic cancer	0.000162	0.00119	CcSEcCtD
Lovastatin—Pruritus—Fluorouracil—pancreatic cancer	0.000161	0.00118	CcSEcCtD
Lovastatin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00016	0.00118	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000159	0.00117	CcSEcCtD
Lovastatin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000158	0.00116	CcSEcCtD
Lovastatin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000157	0.00116	CcSEcCtD
Lovastatin—Dizziness—Irinotecan—pancreatic cancer	0.000157	0.00115	CcSEcCtD
Lovastatin—Anorexia—Docetaxel—pancreatic cancer	0.000156	0.00115	CcSEcCtD
Lovastatin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000156	0.00115	CcSEcCtD
Lovastatin—Hepatitis—Epirubicin—pancreatic cancer	0.000156	0.00115	CcSEcCtD
Lovastatin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000155	0.00114	CcSEcCtD
Lovastatin—Vomiting—Irinotecan—pancreatic cancer	0.000151	0.00111	CcSEcCtD
Lovastatin—Sinusitis—Doxorubicin—pancreatic cancer	0.00015	0.00111	CcSEcCtD
Lovastatin—Dizziness—Fluorouracil—pancreatic cancer	0.00015	0.00111	CcSEcCtD
Lovastatin—Rash—Irinotecan—pancreatic cancer	0.000149	0.0011	CcSEcCtD
Lovastatin—Dermatitis—Irinotecan—pancreatic cancer	0.000149	0.0011	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000149	0.0011	CcSEcCtD
Lovastatin—Headache—Irinotecan—pancreatic cancer	0.000148	0.00109	CcSEcCtD
Lovastatin—Insomnia—Docetaxel—pancreatic cancer	0.000148	0.00109	CcSEcCtD
Lovastatin—Paraesthesia—Docetaxel—pancreatic cancer	0.000147	0.00108	CcSEcCtD
Lovastatin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000147	0.00108	CcSEcCtD
Lovastatin—Vomiting—Gemcitabine—pancreatic cancer	0.000147	0.00108	CcSEcCtD
Lovastatin—Dyspnoea—Docetaxel—pancreatic cancer	0.000146	0.00108	CcSEcCtD
Lovastatin—Rash—Gemcitabine—pancreatic cancer	0.000146	0.00107	CcSEcCtD
Lovastatin—Dermatitis—Gemcitabine—pancreatic cancer	0.000145	0.00107	CcSEcCtD
Lovastatin—Headache—Gemcitabine—pancreatic cancer	0.000145	0.00107	CcSEcCtD
Lovastatin—Flushing—Epirubicin—pancreatic cancer	0.000144	0.00106	CcSEcCtD
Lovastatin—Vomiting—Fluorouracil—pancreatic cancer	0.000144	0.00106	CcSEcCtD
Lovastatin—Dyspepsia—Docetaxel—pancreatic cancer	0.000144	0.00106	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—pancreatic cancer	0.000144	0.00106	CcSEcCtD
Lovastatin—Rash—Fluorouracil—pancreatic cancer	0.000143	0.00105	CcSEcCtD
Lovastatin—Dermatitis—Fluorouracil—pancreatic cancer	0.000143	0.00105	CcSEcCtD
Lovastatin—Decreased appetite—Docetaxel—pancreatic cancer	0.000142	0.00105	CcSEcCtD
Lovastatin—Headache—Fluorouracil—pancreatic cancer	0.000142	0.00105	CcSEcCtD
Lovastatin—Fatigue—Docetaxel—pancreatic cancer	0.000141	0.00104	CcSEcCtD
Lovastatin—Nausea—Irinotecan—pancreatic cancer	0.000141	0.00104	CcSEcCtD
Lovastatin—Pain—Docetaxel—pancreatic cancer	0.00014	0.00103	CcSEcCtD
Lovastatin—Constipation—Docetaxel—pancreatic cancer	0.00014	0.00103	CcSEcCtD
Lovastatin—Chills—Epirubicin—pancreatic cancer	0.00014	0.00103	CcSEcCtD
Lovastatin—Alopecia—Epirubicin—pancreatic cancer	0.000137	0.00101	CcSEcCtD
Lovastatin—Nausea—Gemcitabine—pancreatic cancer	0.000137	0.00101	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000136	0.001	CcSEcCtD
Lovastatin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000135	0.000994	CcSEcCtD
Lovastatin—Nausea—Fluorouracil—pancreatic cancer	0.000135	0.000993	CcSEcCtD
Lovastatin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000134	0.000987	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—pancreatic cancer	0.000134	0.000984	CcSEcCtD
Lovastatin—Flatulence—Epirubicin—pancreatic cancer	0.000133	0.000983	CcSEcCtD
Lovastatin—Dysgeusia—Epirubicin—pancreatic cancer	0.000133	0.000976	CcSEcCtD
Lovastatin—Back pain—Epirubicin—pancreatic cancer	0.000131	0.000965	CcSEcCtD
Lovastatin—Muscle spasms—Epirubicin—pancreatic cancer	0.00013	0.000959	CcSEcCtD
Lovastatin—Body temperature increased—Docetaxel—pancreatic cancer	0.00013	0.000954	CcSEcCtD
Lovastatin—Abdominal pain—Docetaxel—pancreatic cancer	0.00013	0.000954	CcSEcCtD
Lovastatin—Chills—Doxorubicin—pancreatic cancer	0.000129	0.000951	CcSEcCtD
Lovastatin—Vision blurred—Epirubicin—pancreatic cancer	0.000128	0.00094	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—pancreatic cancer	0.000127	0.000937	CcSEcCtD
Lovastatin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000126	0.000925	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—pancreatic cancer	0.000123	0.000909	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000123	0.000903	CcSEcCtD
Lovastatin—Malaise—Epirubicin—pancreatic cancer	0.000122	0.000899	CcSEcCtD
Lovastatin—Vertigo—Epirubicin—pancreatic cancer	0.000122	0.000896	CcSEcCtD
Lovastatin—Leukopenia—Epirubicin—pancreatic cancer	0.000121	0.000893	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—pancreatic cancer	0.000121	0.000892	CcSEcCtD
Lovastatin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000121	0.000889	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—pancreatic cancer	0.00012	0.000887	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—pancreatic cancer	0.000118	0.00087	CcSEcCtD
Lovastatin—Asthenia—Docetaxel—pancreatic cancer	0.000118	0.000866	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000116	0.000856	CcSEcCtD
Lovastatin—Pruritus—Docetaxel—pancreatic cancer	0.000116	0.000854	CcSEcCtD
Lovastatin—Myalgia—Epirubicin—pancreatic cancer	0.000115	0.000849	CcSEcCtD
Lovastatin—Chest pain—Epirubicin—pancreatic cancer	0.000115	0.000849	CcSEcCtD
Lovastatin—Arthralgia—Epirubicin—pancreatic cancer	0.000115	0.000849	CcSEcCtD
Lovastatin—Anxiety—Epirubicin—pancreatic cancer	0.000115	0.000846	CcSEcCtD
Lovastatin—Discomfort—Epirubicin—pancreatic cancer	0.000114	0.000839	CcSEcCtD
Lovastatin—Malaise—Doxorubicin—pancreatic cancer	0.000113	0.000832	CcSEcCtD
Lovastatin—Dry mouth—Epirubicin—pancreatic cancer	0.000113	0.00083	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—pancreatic cancer	0.000113	0.000829	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—pancreatic cancer	0.000112	0.000826	CcSEcCtD
Lovastatin—Diarrhoea—Docetaxel—pancreatic cancer	0.000112	0.000826	CcSEcCtD
Lovastatin—Confusional state—Epirubicin—pancreatic cancer	0.000111	0.000821	CcSEcCtD
Lovastatin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000111	0.000814	CcSEcCtD
Lovastatin—Infection—Epirubicin—pancreatic cancer	0.00011	0.000808	CcSEcCtD
Lovastatin—Dizziness—Docetaxel—pancreatic cancer	0.000108	0.000798	CcSEcCtD
Lovastatin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000108	0.000797	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—pancreatic cancer	0.000107	0.000785	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—pancreatic cancer	0.000107	0.000785	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—pancreatic cancer	0.000107	0.000785	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—pancreatic cancer	0.000106	0.000783	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—pancreatic cancer	0.000105	0.000776	CcSEcCtD
Lovastatin—Anorexia—Epirubicin—pancreatic cancer	0.000105	0.000776	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—pancreatic cancer	0.000104	0.000768	CcSEcCtD
Lovastatin—Vomiting—Docetaxel—pancreatic cancer	0.000104	0.000767	CcSEcCtD
Lovastatin—Rash—Docetaxel—pancreatic cancer	0.000103	0.000761	CcSEcCtD
Lovastatin—Dermatitis—Docetaxel—pancreatic cancer	0.000103	0.00076	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—pancreatic cancer	0.000103	0.000759	CcSEcCtD
Lovastatin—Headache—Docetaxel—pancreatic cancer	0.000103	0.000756	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000102	0.000753	CcSEcCtD
Lovastatin—Infection—Doxorubicin—pancreatic cancer	0.000102	0.000748	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000101	0.000741	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.0001	0.000737	CcSEcCtD
Lovastatin—Insomnia—Epirubicin—pancreatic cancer	0.0001	0.000736	CcSEcCtD
Lovastatin—Paraesthesia—Epirubicin—pancreatic cancer	9.92e-05	0.000731	CcSEcCtD
Lovastatin—Dyspnoea—Epirubicin—pancreatic cancer	9.85e-05	0.000726	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—pancreatic cancer	9.75e-05	0.000718	CcSEcCtD
Lovastatin—Nausea—Docetaxel—pancreatic cancer	9.73e-05	0.000717	CcSEcCtD
Lovastatin—Dyspepsia—Epirubicin—pancreatic cancer	9.73e-05	0.000716	CcSEcCtD
Lovastatin—Decreased appetite—Epirubicin—pancreatic cancer	9.61e-05	0.000707	CcSEcCtD
Lovastatin—Fatigue—Epirubicin—pancreatic cancer	9.53e-05	0.000702	CcSEcCtD
Lovastatin—Constipation—Epirubicin—pancreatic cancer	9.45e-05	0.000696	CcSEcCtD
Lovastatin—Pain—Epirubicin—pancreatic cancer	9.45e-05	0.000696	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.32e-05	0.000686	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—pancreatic cancer	9.25e-05	0.000681	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—pancreatic cancer	9.18e-05	0.000676	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—pancreatic cancer	9.12e-05	0.000671	CcSEcCtD
Lovastatin—Feeling abnormal—Epirubicin—pancreatic cancer	9.11e-05	0.000671	CcSEcCtD
Lovastatin—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.04e-05	0.000665	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—pancreatic cancer	9e-05	0.000663	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—pancreatic cancer	8.89e-05	0.000655	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—pancreatic cancer	8.82e-05	0.000649	CcSEcCtD
Lovastatin—Urticaria—Epirubicin—pancreatic cancer	8.78e-05	0.000646	CcSEcCtD
Lovastatin—Pain—Doxorubicin—pancreatic cancer	8.74e-05	0.000644	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—pancreatic cancer	8.74e-05	0.000644	CcSEcCtD
Lovastatin—Body temperature increased—Epirubicin—pancreatic cancer	8.74e-05	0.000643	CcSEcCtD
Lovastatin—Abdominal pain—Epirubicin—pancreatic cancer	8.74e-05	0.000643	CcSEcCtD
Lovastatin—Feeling abnormal—Doxorubicin—pancreatic cancer	8.43e-05	0.00062	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.36e-05	0.000616	CcSEcCtD
Lovastatin—Hypersensitivity—Epirubicin—pancreatic cancer	8.14e-05	0.0006	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—pancreatic cancer	8.12e-05	0.000598	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—pancreatic cancer	8.08e-05	0.000595	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—pancreatic cancer	8.08e-05	0.000595	CcSEcCtD
Lovastatin—Asthenia—Epirubicin—pancreatic cancer	7.93e-05	0.000584	CcSEcCtD
Lovastatin—Pruritus—Epirubicin—pancreatic cancer	7.82e-05	0.000576	CcSEcCtD
Lovastatin—Diarrhoea—Epirubicin—pancreatic cancer	7.56e-05	0.000557	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—pancreatic cancer	7.53e-05	0.000555	CcSEcCtD
Lovastatin—Asthenia—Doxorubicin—pancreatic cancer	7.34e-05	0.00054	CcSEcCtD
Lovastatin—Dizziness—Epirubicin—pancreatic cancer	7.31e-05	0.000538	CcSEcCtD
Lovastatin—Pruritus—Doxorubicin—pancreatic cancer	7.24e-05	0.000533	CcSEcCtD
Lovastatin—Vomiting—Epirubicin—pancreatic cancer	7.03e-05	0.000517	CcSEcCtD
Lovastatin—Diarrhoea—Doxorubicin—pancreatic cancer	7e-05	0.000515	CcSEcCtD
Lovastatin—Rash—Epirubicin—pancreatic cancer	6.97e-05	0.000513	CcSEcCtD
Lovastatin—Dermatitis—Epirubicin—pancreatic cancer	6.96e-05	0.000513	CcSEcCtD
Lovastatin—Headache—Epirubicin—pancreatic cancer	6.92e-05	0.00051	CcSEcCtD
Lovastatin—Dizziness—Doxorubicin—pancreatic cancer	6.76e-05	0.000498	CcSEcCtD
Lovastatin—Nausea—Epirubicin—pancreatic cancer	6.56e-05	0.000483	CcSEcCtD
Lovastatin—Vomiting—Doxorubicin—pancreatic cancer	6.5e-05	0.000479	CcSEcCtD
Lovastatin—Rash—Doxorubicin—pancreatic cancer	6.45e-05	0.000475	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—pancreatic cancer	6.44e-05	0.000474	CcSEcCtD
Lovastatin—Headache—Doxorubicin—pancreatic cancer	6.41e-05	0.000472	CcSEcCtD
Lovastatin—Nausea—Doxorubicin—pancreatic cancer	6.07e-05	0.000447	CcSEcCtD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.37e-05	0.000156	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.36e-05	0.000156	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—pancreatic cancer	1.36e-05	0.000155	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HIF1A—pancreatic cancer	1.35e-05	0.000155	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TSC2—pancreatic cancer	1.35e-05	0.000155	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—AKT1—pancreatic cancer	1.34e-05	0.000154	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—STK11—pancreatic cancer	1.34e-05	0.000154	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.34e-05	0.000153	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOE—pancreatic cancer	1.32e-05	0.000152	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.32e-05	0.000151	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.31e-05	0.00015	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CB—pancreatic cancer	1.31e-05	0.00015	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.3e-05	0.000149	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KDR—pancreatic cancer	1.3e-05	0.000148	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—pancreatic cancer	1.29e-05	0.000148	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.29e-05	0.000147	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CD—pancreatic cancer	1.28e-05	0.000147	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.27e-05	0.000146	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.27e-05	0.000145	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.26e-05	0.000145	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.26e-05	0.000144	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	1.24e-05	0.000142	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NFKBIA—pancreatic cancer	1.23e-05	0.000141	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOTCH1—pancreatic cancer	1.22e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.2e-05	0.000138	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PPARG—pancreatic cancer	1.19e-05	0.000137	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOE—pancreatic cancer	1.19e-05	0.000137	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CG—pancreatic cancer	1.19e-05	0.000137	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.19e-05	0.000136	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTEN—pancreatic cancer	1.18e-05	0.000135	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGF—pancreatic cancer	1.18e-05	0.000135	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.18e-05	0.000135	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.16e-05	0.000133	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CTNNB1—pancreatic cancer	1.16e-05	0.000133	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TYMS—pancreatic cancer	1.15e-05	0.000132	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.15e-05	0.000132	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.15e-05	0.000132	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.13e-05	0.00013	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.13e-05	0.00013	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.13e-05	0.00013	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTEN—pancreatic cancer	1.13e-05	0.000129	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.12e-05	0.000128	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.12e-05	0.000128	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CB—pancreatic cancer	1.12e-05	0.000128	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOE—pancreatic cancer	1.11e-05	0.000128	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—pancreatic cancer	1.11e-05	0.000127	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—DPYD—pancreatic cancer	1.1e-05	0.000126	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	1.09e-05	0.000125	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.08e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CD44—pancreatic cancer	1.07e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.07e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.07e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.06e-05	0.000122	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.06e-05	0.000121	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CD—pancreatic cancer	1.05e-05	0.00012	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.05e-05	0.00012	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.05e-05	0.00012	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SRC—pancreatic cancer	1.05e-05	0.00012	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.05e-05	0.00012	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.04e-05	0.000119	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.04e-05	0.000119	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.03e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GCG—pancreatic cancer	1.03e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.02e-05	0.000117	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.02e-05	0.000117	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—pancreatic cancer	1.01e-05	0.000116	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—pancreatic cancer	1.01e-05	0.000116	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NRAS—pancreatic cancer	1.01e-05	0.000115	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	1.01e-05	0.000115	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	9.87e-06	0.000113	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.81e-06	0.000112	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	9.78e-06	0.000112	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PPARG—pancreatic cancer	9.71e-06	0.000111	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—STK11—pancreatic cancer	9.68e-06	0.000111	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.68e-06	0.000111	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.67e-06	0.000111	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTEN—pancreatic cancer	9.64e-06	0.00011	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	9.48e-06	0.000109	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	9.47e-06	0.000109	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	9.47e-06	0.000108	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—pancreatic cancer	9.4e-06	0.000108	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—pancreatic cancer	9.38e-06	0.000107	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOE—pancreatic cancer	9.37e-06	0.000107	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—pancreatic cancer	9.36e-06	0.000107	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.34e-06	0.000107	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.33e-06	0.000107	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CD44—pancreatic cancer	9.31e-06	0.000107	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	9.22e-06	0.000106	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—pancreatic cancer	9.17e-06	0.000105	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CB—pancreatic cancer	9.15e-06	0.000105	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.11e-06	0.000104	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.03e-06	0.000103	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GCG—pancreatic cancer	8.92e-06	0.000102	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PPARG—pancreatic cancer	8.9e-06	0.000102	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	8.84e-06	0.000101	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—pancreatic cancer	8.79e-06	0.000101	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—pancreatic cancer	8.67e-06	9.93e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.57e-06	9.82e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.51e-06	9.75e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	8.46e-06	9.69e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—pancreatic cancer	8.41e-06	9.64e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—STK11—pancreatic cancer	8.39e-06	9.61e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—pancreatic cancer	8.34e-06	9.56e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TYMS—pancreatic cancer	8.33e-06	9.54e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CD44—pancreatic cancer	8.31e-06	9.52e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	8.26e-06	9.46e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—pancreatic cancer	8.2e-06	9.39e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—pancreatic cancer	8.19e-06	9.38e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	8.18e-06	9.38e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARG—pancreatic cancer	8.16e-06	9.35e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.13e-06	9.32e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CTNNB1—pancreatic cancer	8.11e-06	9.29e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CD44—pancreatic cancer	8.11e-06	9.29e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	8.1e-06	9.28e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.06e-06	9.23e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GCG—pancreatic cancer	7.96e-06	9.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—pancreatic cancer	7.96e-06	9.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—pancreatic cancer	7.95e-06	9.11e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—pancreatic cancer	7.9e-06	9.06e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.87e-06	9.02e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GCG—pancreatic cancer	7.77e-06	8.91e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	7.71e-06	8.83e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CD44—pancreatic cancer	7.64e-06	8.75e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—pancreatic cancer	7.64e-06	8.75e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CD44—pancreatic cancer	7.57e-06	8.68e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—STK11—pancreatic cancer	7.49e-06	8.58e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	7.44e-06	8.52e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.42e-06	8.5e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—pancreatic cancer	7.37e-06	8.44e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.35e-06	8.42e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SRC—pancreatic cancer	7.33e-06	8.4e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GCG—pancreatic cancer	7.32e-06	8.39e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—STK11—pancreatic cancer	7.31e-06	8.37e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GCG—pancreatic cancer	7.26e-06	8.32e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TYMS—pancreatic cancer	7.22e-06	8.27e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—pancreatic cancer	7.14e-06	8.18e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—pancreatic cancer	7.14e-06	8.18e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—pancreatic cancer	7.07e-06	8.1e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	7.06e-06	8.09e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NRAS—pancreatic cancer	7.05e-06	8.08e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.03e-06	8.05e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—pancreatic cancer	7.01e-06	8.03e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	7e-06	8.02e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.91e-06	7.92e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—STK11—pancreatic cancer	6.89e-06	7.89e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—STK11—pancreatic cancer	6.83e-06	7.82e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—pancreatic cancer	6.81e-06	7.81e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	6.8e-06	7.79e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.8e-06	7.79e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOE—pancreatic cancer	6.78e-06	7.76e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—pancreatic cancer	6.66e-06	7.63e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—pancreatic cancer	6.57e-06	7.53e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—pancreatic cancer	6.55e-06	7.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—pancreatic cancer	6.5e-06	7.45e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	6.48e-06	7.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.45e-06	7.39e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TYMS—pancreatic cancer	6.44e-06	7.38e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—pancreatic cancer	6.42e-06	7.36e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—pancreatic cancer	6.42e-06	7.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.41e-06	7.34e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TYMS—pancreatic cancer	6.29e-06	7.2e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	6.11e-06	7.01e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—pancreatic cancer	6.1e-06	6.99e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—pancreatic cancer	6.07e-06	6.95e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.92e-06	6.79e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARG—pancreatic cancer	5.9e-06	6.76e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.87e-06	6.73e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOE—pancreatic cancer	5.87e-06	6.72e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	5.78e-06	6.62e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—pancreatic cancer	5.6e-06	6.42e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—pancreatic cancer	5.58e-06	6.39e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.55e-06	6.36e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—pancreatic cancer	5.55e-06	6.36e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—pancreatic cancer	5.39e-06	6.18e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	5.38e-06	6.16e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	5.3e-06	6.07e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOE—pancreatic cancer	5.24e-06	6e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—pancreatic cancer	5.16e-06	5.91e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOE—pancreatic cancer	5.11e-06	5.86e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARG—pancreatic cancer	5.11e-06	5.86e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	5.03e-06	5.77e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CD44—pancreatic cancer	4.99e-06	5.72e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.96e-06	5.68e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOE—pancreatic cancer	4.82e-06	5.52e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCG—pancreatic cancer	4.79e-06	5.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOE—pancreatic cancer	4.78e-06	5.47e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.73e-06	5.42e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—pancreatic cancer	4.72e-06	5.41e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	4.7e-06	5.38e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	4.69e-06	5.37e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.66e-06	5.33e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—pancreatic cancer	4.64e-06	5.32e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.61e-06	5.29e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARG—pancreatic cancer	4.56e-06	5.23e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—pancreatic cancer	4.55e-06	5.22e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.52e-06	5.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—STK11—pancreatic cancer	4.5e-06	5.16e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARG—pancreatic cancer	4.45e-06	5.1e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.35e-06	4.98e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.31e-06	4.94e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	4.31e-06	4.93e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.2e-06	4.81e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARG—pancreatic cancer	4.16e-06	4.77e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	4.16e-06	4.76e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—pancreatic cancer	4.11e-06	4.71e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	4.06e-06	4.65e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	4.06e-06	4.65e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—pancreatic cancer	4.05e-06	4.64e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—pancreatic cancer	4.02e-06	4.61e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	3.95e-06	4.53e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.87e-06	4.44e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—pancreatic cancer	3.84e-06	4.4e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.82e-06	4.38e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.79e-06	4.34e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.62e-06	4.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.59e-06	4.11e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.54e-06	4.05e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—pancreatic cancer	3.52e-06	4.03e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.51e-06	4.02e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.5e-06	4.01e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.33e-06	3.82e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.3e-06	3.78e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.3e-06	3.78e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.27e-06	3.75e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—pancreatic cancer	3.23e-06	3.7e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOE—pancreatic cancer	3.15e-06	3.61e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—pancreatic cancer	3.13e-06	3.59e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—pancreatic cancer	3.06e-06	3.5e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.88e-06	3.3e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.86e-06	3.27e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.85e-06	3.27e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.84e-06	3.26e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.74e-06	3.14e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.5e-06	2.86e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.47e-06	2.83e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.33e-06	2.67e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.18e-06	2.5e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.16e-06	2.47e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	2.47e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.03e-06	2.33e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.02e-06	2.32e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.01e-06	2.31e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.88e-06	2.16e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.8e-06	2.07e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—pancreatic cancer	1.76e-06	2.02e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.66e-06	1.9e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.64e-06	1.88e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.33e-06	1.52e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.08e-06	1.24e-05	CbGpPWpGaD
